Syneos Health, Inc. (SYNH) to Offer Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Syneos Health Announces Secondary Offering of Common Stock
June 2, 2021 4:01 PM EDTMORRISVILLE, N.C., June 02, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the Company or Syneos Health), the only fully integrated biopharmaceutical solutions organization, today announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation (the Selling Stockholders) of an aggregate of 10,851,676 shares of the Companys common stock (the Offering) pursuant to the Companys shelf registration statement filed with the Securities and Exchange Commission (SEC). Syneos Health is not selling any shares and will not receive any proceeds from the sale of the shares by the Selling... More



